Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Nautilus Biotechnology, Inc. | 160,000 | reported | 02 Mar 2026 | tx 4+589,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Mar 2026 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 160,000 | 0.00 USD | deriv |
| 06 Nov 2025 | PURCHASE | Nautilus Biotechnology, Inc. | 4,000 | 1.49 USD | |
| 03 Mar 2025 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 50,000 | 0.00 USD | deriv |
| 16 Sept 2024 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 375,000 | 0.00 USD | deriv |